The Homeopathic Pharmacopoeia Convention of the United States Continues to Play a Vital Role
By Mark Land, AAHP President The first edition of the Homeopathic Pharmacopoeia of the United States (HPUS) was first published in 1897 — 125 years ago! Since FDA’s 2019 draft…
Read MoreCase Study: Updating & Revising HPUS Monographs
By Eric Foxman, Pharm. (Ret.), AAHP Secretary | What is the process through which the Homeopathic Pharmacopeia Convention of the United States (HPCUS) revises monographs? What role can subscribers and non-members play in this activity?
Read MoreBe ’Recall Ready’: FDA Wants to Help You Fulfill Your Regulatory Requirements
By Eric Foxman, AAHP Secretary Does your company market or distribute an FDA-regulated product? If so, then FDA has a document for you. FDA wants all manufacturers and downstream distribution…
Read MoreHomeopathic Community Responds to BJM Article on Reporting Bias
By Mark Land, AAHP President You may have seen recent reports about a new study claiming that most homeopathic research is of poor quality, with positive results overestimated. AAHP…
Read MoreMastering the Master Service Agreement (MSA)
Supply Chain Management for Homeopathy, Part 4 of 4 By Tim Clarot, Industry Consultant The final element of a good supply chain structure is the Master Service Agreement. The MSA…
Read MoreMeet the Incumbent FDA Commissioner, Robert Califf, MD
Prominent cardiologist Robert Califf, MD, will once again serve as FDA Commissioner after being confirmed by the Senate on Feb. 15. Dr. Califf was first nominated to the position by…
Read MoreUshering in CPG 400.400 & Modern Homeopathy: Interview with Al Lorman
For those in the AAHP community who don’t know him already, we’re thrilled to introduce you to Alvin J. Lorman. Not only is Al our legal counsel, but he has…
Read MoreHomeopathic Community Mourns the Loss of Researcher Luc Montagnier
The French virologist Luc Montagnier who won the Nobel Prize in 2008 for discovering the AIDS virus passed away on Feb. 8, 2022 in the Paris suburb of Neuilly-sur-Seine. He…
Read MoreCongress Begins Work on FDA User Fee Reauthorization Measure
By Mark Land, AAHP President This year marks the 30th anniversary of the enactment of the Prescription Drug User Fee Act (PDUFA). Enacted in 1992, PDUFA authorized FDA to collect…
Read MoreAAHP Submits Comments and Briefs Industry on New FDA Requirements
In November 2021, FDA announced a guidance regarding annual reporting of quantities of drugs manufactured or compounded. The deadline for the first reports, covering quantities produced in 2020, is Feb.…
Read More